Skip Navigation
Department of Health and Human Services
  • Home
  • Search for Research Summaries, Reviews, and Reports
Maintenance Notice
An infrastructure upgrade will take place on Friday, December 19 at approximately 2PM Eastern time. Please be aware you may experience temporary issues accessing the site at that point.

Research Review - Final – Aug. 14, 2012

First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness


Notice of Erratum: On August 20, 2012, Appendix O was updated to clarify that the route of administration for INVEGA SUSTENNA is IM injection (dosage 39 mg - 234 mg) and the route of administration for RISPERIDOL CONSTA is IM injection (dosage 25 mg).

People using assistive technology may not be able to fully access information in these files. For additional assistance, please contact us.



Return to Top of Page